TRPC5 is expressed in podocytes [13, 49, 50] and has been suggested to play a role in nephrotic syndromes [51, 52] and can be mobilized to surface under in vitro conditions designed to mimic severe primary FSGS [13]. This evidence concerns the gene TRPC5 and focal segmental glomerulosclerosis.